Literature DB >> 23802121

Modulation of interpersonal trust in borderline personality disorder by intranasal oxytocin and childhood trauma.

Andreas Ebert1, Meike Kolb, Jörg Heller, Marc-Andreas Edel, Patrik Roser, Martin Brüne.   

Abstract

Borderline personality disorder (BPD) is characterized by interpersonal difficulties, whereby patients are negatively biased concerning the evaluation of others' trustworthiness. Here, we examined the effect of oxytocin on interpersonal behavior of BPD patients in a trust game, emphasizing the assessment of facial attractiveness of the patients' counterparts in the game, and patients' history of childhood trauma. Thirteen BPD patients and thirteen healthy controls played a trust game after receiving oxytocin or placebo in a randomized, double-blind crossover design. Childhood trauma was evaluated using the Childhood Trauma Questionnaire (CTQ). Patients transferred less money in the oxytocin condition compared to placebo. While healthy controls transferred more money units (MUs) to attractive counterparts than to unattractive ones only after the administration of oxytocin, BPD patients showed this pattern in both conditions. Emotional neglect during childhood negatively correlated with the amount of MUs transferred by patients under oxytocin, but not placebo. Oxytocin had a trust-lowering effect in BPD, which was correlated with patients' history of childhood trauma. Patients' evaluation of interpersonal trust seems to depend more on attractiveness features of their counterparts than in controls, a finding that may have important implications for further research on the usefulness of "prosocial" peptides as an adjunct to psychotherapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23802121     DOI: 10.1080/17470919.2013.807301

Source DB:  PubMed          Journal:  Soc Neurosci        ISSN: 1747-0919            Impact factor:   2.083


  18 in total

Review 1.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

Authors:  Philip Kamilar-Britt; Gillinder Bedi
Journal:  Neurosci Biobehav Rev       Date:  2015-09-25       Impact factor: 8.989

Review 2.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

Review 3.  Pharmacotherapy for borderline personality disorder--current evidence and recent trends.

Authors:  Jutta M Stoffers; Klaus Lieb
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

4.  Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.

Authors:  Julianne C Flanagan; Lauren M Sippel; Amy Wahlquist; Megan M Moran-Santa Maria; Sudie E Back
Journal:  J Psychiatr Res       Date:  2017-12-26       Impact factor: 4.791

5.  A registered replication study on oxytocin and trust.

Authors:  Carolyn H Declerck; Christophe Boone; Loren Pauwels; Bodo Vogt; Ernst Fehr
Journal:  Nat Hum Behav       Date:  2020-06-08

Review 6.  Affiliative and prosocial motives and emotions in mental health.

Authors:  Paul Gilbert
Journal:  Dialogues Clin Neurosci       Date:  2015-12       Impact factor: 5.986

Review 7.  Borderline Personality Disorder: Why 'fast and furious'?

Authors:  Martin Brüne
Journal:  Evol Med Public Health       Date:  2016-02-28

Review 8.  Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum.

Authors:  Martin Debbané; George Salaminios; Patrick Luyten; Deborah Badoud; Marco Armando; Alessandra Solida Tozzi; Peter Fonagy; Benjamin K Brent
Journal:  Front Hum Neurosci       Date:  2016-08-22       Impact factor: 3.169

Review 9.  Neural substrates underlying the effects of oxytocin: a quantitative meta-analysis of pharmaco-imaging studies.

Authors:  Danyang Wang; Xinyuan Yan; Ming Li; Yina Ma
Journal:  Soc Cogn Affect Neurosci       Date:  2017-10-01       Impact factor: 3.436

10.  Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations.

Authors:  Andrea Jobst; Frank Padberg; Maria-Christine Mauer; Tanja Daltrozzo; Christine Bauriedl-Schmidt; Lena Sabass; Nina Sarubin; Peter Falkai; Babette Renneberg; Peter Zill; Manuela Gander; Anna Buchheim
Journal:  Front Hum Neurosci       Date:  2016-03-30       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.